{
    "Symbol": "LEGN",
    "AssetType": "Common Stock",
    "Name": "Legend Biotech\u00a0Corp",
    "Description": "Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology and other indications in North America and internationally. ",
    "CIK": "1801198",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "2101 COTTONTAIL LANE, SOMERSET, NJ, UNITED STATES",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "10025565000",
    "EBITDA": "-425375008",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "6.39",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-2.58",
    "RevenuePerShareTTM": "1.902",
    "ProfitMargin": "-1.359",
    "OperatingMarginTTM": "-1.254",
    "ReturnOnAssetsTTM": "-0.182",
    "ReturnOnEquityTTM": "-0.513",
    "RevenueTTM": "342798000",
    "GrossProfitTTM": "-284006000",
    "DilutedEPSTTM": "-2.58",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "1.587",
    "AnalystTargetPrice": "82.43",
    "AnalystRatingStrongBuy": "7",
    "AnalystRatingBuy": "15",
    "AnalystRatingHold": "2",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "33.76",
    "PriceToBookRatio": "7.69",
    "EVToRevenue": "30.32",
    "EVToEBITDA": "-18.09",
    "Beta": "0.111",
    "52WeekHigh": "72.62",
    "52WeekLow": "38.6",
    "50DayMovingAverage": "47.72",
    "200DayMovingAverage": "55.73",
    "SharesOutstanding": "182283000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}